This inventor holds 29 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Heptares Therapeutics Limited, Nxera Pharma UK Limited, Other. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hertfordshire, GB (2015 - 2016)
- Welwyn Garden, GB (2017 - 2019)
- Welwyn Garden City, GB (2017 - 2019)
- Cambridge, GB (2019 - 2024)
Company Filing History:
25 out of 85 
3 out of 18 
1 out of 834,601 Years Active: 2015-2025
Areas of Expertise:
Title: Innovations and Patents of Julie Elaine Cansfield
Introduction
Julie Elaine Cansfield is a prominent inventor based in Cambridge, GB, known for her significant contributions to the field of pharmaceuticals. With an impressive portfolio of 28 patents, Cansfield has focused her research on compounds that target specific receptors associated with various medical conditions.
Latest Patents
Cansfield's latest innovations include several noteworthy patents. One of her significant patents involves CGRP antagonist compounds, where the disclosures pertain to novel compounds of Formula (1a) and their salts. These compounds are aimed at treating, preventing, ameliorating, controlling, or reducing the risk of disorders associated with CGRP receptors. Another patent focuses on muscarinic receptor agonists, relating to compounds that act as agonists of the muscarinic M receptor. These compounds are valuable in treating diseases mediated by the muscarinic M receptor, with corresponding pharmaceutical compositions and therapeutic applications detailed in her disclosures.
Career Highlights
Throughout her career, Cansfield has worked with notable companies in the biotechnology sector, including Heptares Therapeutics Limited and Nxera Pharma UK Limited. Her work in these organizations has contributed significantly to the advancement of pharmacological research and the development of innovative therapeutic solutions.
Collaborations
In her endeavors, Julie has collaborated with esteemed professionals such as Giles Albert Brown and Benjamin Gerald Tehan. These partnerships have been instrumental in fostering a creative environment for innovation and enhancing the overall quality of the research conducted.
Conclusion
Julie Elaine Cansfield stands out as a leading inventor in the pharmaceutical field, with a strong focus on developing novel therapeutic compounds. Her contributions, reflected in her numerous patents, highlight her commitment to addressing complex medical challenges through scientific innovation. Her collaborations and career achievements continue to shape the landscape of pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile